{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:02:24Z","timestamp":1792674144109,"version":"4.5.0"},"reference-count":34,"publisher":"American Association for Cancer Research (AACR)","issue":"10","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The role that cell-mediated immune responses play during cutaneous carcinogenesis has received little attention. In this study, we evaluated the contribution of CD4+ and CD8+ T cells in C3H\/HeN mice that were subjected to a two-stage 7,12-dimethylbenz(a)anthracene (DMBA) initiation, 12-O-tetradecanoylphorbol-13-acetate (TPA) promotion skin carcinogenesis protocol. In CD8 knockout (CD8\u2212\/\u2212) mice, allergic contact hypersensitivity to DMBA was reduced compared with wild-type (WT) C3H\/HeN mice. On the other hand, CD4 knockout (CD4\u2212\/\u2212) mice developed an exaggerated contact hypersensitivity response. CD4+ T cells from DMBA contact\u2013sensitized mice preferentially produced interleukin 4 (IL-4), IL-10, and IL-17; CD8+ T cells, on the other hand, secreted IFN-\u03b3. When CD4\u2212\/\u2212, CD8\u2212\/\u2212, and WT mice were subjected to a standard two-stage DMBA\/TPA cutaneous carcinogenesis protocol, the percentage of mice with tumors was much greater (P &amp;lt; 0.001) in CD8\u2212\/\u2212 mice than in WT mice. In contrast, the percentage of tumors was significantly less (P &amp;lt; 0.001) in CD4\u2212\/\u2212 mice than in WT mice. Similar results were obtained when the data were evaluated as the number of tumors per mouse. These findings indicate that (a) CD8+ T cells are the predominant effector cells in allergic contact hypersensitivity to DMBA and that CD4+ T cells have an inhibitory role and (b) the development of CD8+ T cells plays a protective role in skin tumor development whereas CD4+ T cells have the opposite effect. Manipulation of T-cell subpopulations that are induced by carcinogenic chemicals, like DMBA, could be a means of preventing skin cancers caused by these agents. [Cancer Res 2008;68(10):3924\u201330]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-3059","type":"journal-article","created":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T18:14:48Z","timestamp":1210875288000},"page":"3924-3930","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Antagonistic Roles of CD4+ and CD8+ T-Cells in 7,12-Dimethylbenz(<i>a<\/i>)anthracene Cutaneous Carcinogenesis"],"prefix":"10.1158","volume":"68","author":[{"given":"Nabiha","family":"Yusuf","sequence":"first","affiliation":[{"name":"1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham and"},{"name":"2Birmingham VA Medical Center, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahseen H.","family":"Nasti","sequence":"additional","affiliation":[{"name":"1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh K.","family":"Katiyar","sequence":"additional","affiliation":[{"name":"1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan D.","family":"Seibert","sequence":"additional","affiliation":[{"name":"1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis C.","family":"Ginsburg","sequence":"additional","affiliation":[{"name":"1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Timares","sequence":"additional","affiliation":[{"name":"1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham and"},{"name":"2Birmingham VA Medical Center, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[{"name":"1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham and"},{"name":"2Birmingham VA Medical Center, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Elmets","sequence":"additional","affiliation":[{"name":"1Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham and"},{"name":"2Birmingham VA Medical Center, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,5,15]]},"reference":[{"key":"2022061700302843200_B1","unstructured":"Mukhtar H, Mercurio M, Agarwal R. Murine skin carcinogenesis: relevance to humans. In: Mukhtar H, editor. Skin cancer: mechanisms and human relevance. Boca Raton: CRC Press; 1995. p. 3\u20138."},{"key":"2022061700302843200_B2","doi-asserted-by":"crossref","unstructured":"DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther\u20081992; 54: 63\u2013128.","DOI":"10.1016\/0163-7258(92)90051-Z"},{"key":"2022061700302843200_B3","doi-asserted-by":"crossref","unstructured":"Quintanilla M, Brown K, Ramsden M, Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature\u20081986; 322: 78\u201380.","DOI":"10.1038\/322078a0"},{"key":"2022061700302843200_B4","doi-asserted-by":"crossref","unstructured":"Brown K, Buchmann A, Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc Natl Acad Sci U S A\u20081990; 87: 538\u201342.","DOI":"10.1073\/pnas.87.2.538"},{"key":"2022061700302843200_B5","doi-asserted-by":"crossref","unstructured":"Bizub D, Wood AW, Skalka AM. Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc Natl Acad Sci U S A\u20081986; 83: 6048\u201352.","DOI":"10.1073\/pnas.83.16.6048"},{"key":"2022061700302843200_B6","doi-asserted-by":"crossref","unstructured":"Pelling JC, Fischer SM, Neades R, Strawhecker J, Schweickert L. Elevated expression and point mutation of the Ha-ras proto-oncogene in mouse skin tumors promoted by benzoyl peroxide and other promoting agents. Carcinogenesis\u20081987; 8: 1481\u20134.","DOI":"10.1093\/carcin\/8.10.1481"},{"key":"2022061700302843200_B7","unstructured":"DiGiovanni J. Genetic factors controlling responsiveness to skin tumor promotion in mice. Prog Clin Biol Res\u20081995; 391: 195\u2013212."},{"key":"2022061700302843200_B8","doi-asserted-by":"crossref","unstructured":"Mandelboim O, Vadai E, Fridkin M, et al. Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides. Nat Med\u20081995; 1: 1179\u201383.","DOI":"10.1038\/nm1195-1179"},{"key":"2022061700302843200_B9","doi-asserted-by":"crossref","unstructured":"Morgan RA, Dudley ME, Wunderlich JR, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science\u20082006; 314: 126\u20139.","DOI":"10.1126\/science.1129003"},{"key":"2022061700302843200_B10","doi-asserted-by":"crossref","unstructured":"Girardi M, Oppenheim DE, Steele CR, et al. Regulation of cutaneous malignancy by \u03b3\u03b4 T cells. Science\u20082001; 294: 605\u20139.","DOI":"10.1126\/science.1063916"},{"key":"2022061700302843200_B11","doi-asserted-by":"crossref","unstructured":"Girardi M, Glusac E, Filler RB, et al. The distinct contributions of murine T cell receptor (TCR){\u03b3}{\u03b4}+ and TCR{\u03b1}{\u03b2}+ T cells to different stages of chemically induced skin cancer. J Exp Med\u20082003; 198: 747\u201355.","DOI":"10.1084\/jem.20021282"},{"key":"2022061700302843200_B12","doi-asserted-by":"crossref","unstructured":"Daniel D, Meyer-Morse N, Bergsland EK, Dehne K, Coussens LM, Hanahan D. Immune enhancement of skin carcinogenesis by CD4+ T cells. J Exp Med\u20082003; 197: 1017\u201328.","DOI":"10.1084\/jem.20021047"},{"key":"2022061700302843200_B13","doi-asserted-by":"crossref","unstructured":"Anderson C, Hehr A, Robbins R, et al. Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. J Immunol\u20081995; 155: 3530\u20137.","DOI":"10.4049\/jimmunol.155.7.3530"},{"key":"2022061700302843200_B14","unstructured":"Klemme J, Mukhtar H, Elmets C. Induction of contact hypersensitivity to dimethylbenz[a]anthracene and benzo[a]pyrene in C3H\/HeN mice. Cancer Res\u20081987; 47: 6074\u20138."},{"key":"2022061700302843200_B15","doi-asserted-by":"crossref","unstructured":"Elmets C, Athar M, Tubesing K, Rothaupt D, Xu H, Mukhtar H. Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex. Proc Natl Acad Sci U S A\u20081998; 95: 14915\u20139.","DOI":"10.1073\/pnas.95.25.14915"},{"key":"2022061700302843200_B16","doi-asserted-by":"crossref","unstructured":"Gould K, Dietrich W, Borenstein N, Lander E, Dove W. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min\/+ mice. Genetics\u20081996; 144: 1769\u201376.","DOI":"10.1093\/genetics\/144.4.1769"},{"key":"2022061700302843200_B17","doi-asserted-by":"crossref","unstructured":"Marcela P, Su P, Ebeling C, et al. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat Genet\u20081997; 17: 280\u20134.","DOI":"10.1038\/ng1197-280"},{"key":"2022061700302843200_B18","unstructured":"Elmets CA, Zaidi SI, Bickers DR, Mukhtar H. Immunogenetic influences on the initiation stage of the cutaneous chemical carcinogenesis pathway. Cancer Res\u20081992; 52: 6106\u20139."},{"key":"2022061700302843200_B19","doi-asserted-by":"crossref","unstructured":"Xu H, DiIulio N, Fairchild R. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon \u03b3-producing (Tc1) effector CD8+ T cells and interleukin (IL) 4\/IL-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med\u20081996; 183: 1001\u201312.","DOI":"10.1084\/jem.183.3.1001"},{"key":"2022061700302843200_B20","doi-asserted-by":"crossref","unstructured":"Yusuf N, Nasti TH, Long JA, et al. Protective Role of Toll-like Receptor 4 during the initiation stage of cutaneous chemical carcinogenesis. Cancer Res\u20082008; 68: 615\u201322.","DOI":"10.1158\/0008-5472.CAN-07-5219"},{"key":"2022061700302843200_B21","doi-asserted-by":"crossref","unstructured":"He D, Wu L, Kim HK, Li H, Elmets CA, Xu H. CD8+ IL-17-producing T Cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol\u20082006; 177: 6852\u20138.","DOI":"10.4049\/jimmunol.177.10.6852"},{"key":"2022061700302843200_B22","doi-asserted-by":"crossref","unstructured":"Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity\u20082004; 21: 137\u201348.","DOI":"10.1016\/j.immuni.2004.07.017"},{"key":"2022061700302843200_B23","doi-asserted-by":"crossref","unstructured":"Dunn GP, Old LJ, Schreiber RD. The Three Es of cancer immunoediting. Annu Rev Immunol\u20082004; 22: 329\u201360.","DOI":"10.1146\/annurev.immunol.22.012703.104803"},{"key":"2022061700302843200_B24","doi-asserted-by":"crossref","unstructured":"Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol\u20082002; 71: 1\u20138.","DOI":"10.1189\/jlb.71.1.1"},{"key":"2022061700302843200_B25","doi-asserted-by":"crossref","unstructured":"Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity\u20082004; 21: 467\u201376.","DOI":"10.1016\/j.immuni.2004.08.018"},{"key":"2022061700302843200_B26","doi-asserted-by":"crossref","unstructured":"Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-[\u03b2] induces development of the TH17 lineage. Nature\u20082006; 441: 231\u20134.","DOI":"10.1038\/nature04754"},{"key":"2022061700302843200_B27","doi-asserted-by":"crossref","unstructured":"Yao Z, Fanslow WC, Seldin MF, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity\u20081995; 3: 811\u201321.","DOI":"10.1016\/1074-7613(95)90070-5"},{"key":"2022061700302843200_B28","doi-asserted-by":"crossref","unstructured":"Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med\u20082005; 201: 233\u201340.","DOI":"10.1084\/jem.20041257"},{"key":"2022061700302843200_B29","doi-asserted-by":"crossref","unstructured":"Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol\u20082006; 177: 566\u201373.","DOI":"10.4049\/jimmunol.177.1.566"},{"key":"2022061700302843200_B30","doi-asserted-by":"crossref","unstructured":"Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol\u20082005; 175: 6177\u201389.","DOI":"10.4049\/jimmunol.175.9.6177"},{"key":"2022061700302843200_B31","doi-asserted-by":"crossref","unstructured":"Honorati MC, Neri S, Cattini L, Facchini, A. IL-17 enhances the susceptibility of U-2 OS osteosarcoma cells to NK cell lysis. Clin Exp Immunol\u20082003; 133: 344\u20139.","DOI":"10.1046\/j.1365-2249.2003.02234.x"},{"key":"2022061700302843200_B32","doi-asserted-by":"crossref","unstructured":"Numasaki M, Fukushi J, Ono M, et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood\u20082003; 101: 2620\u20137.","DOI":"10.1182\/blood-2002-05-1461"},{"key":"2022061700302843200_B33","doi-asserted-by":"crossref","unstructured":"Benchetrit F, Ciree A, Vives V, et al. Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood\u20082002; 99: 2114\u201321.","DOI":"10.1182\/blood.V99.6.2114"},{"key":"2022061700302843200_B34","unstructured":"Tartour E, Fossiez F, Joyeux I, et al. Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res\u20081999; 59: 3698\u2013704."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/10\/3924\/2593568\/3924.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/10\/3924\/2593568\/3924.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T11:01:00Z","timestamp":1684407660000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/10\/3924\/540831\/Antagonistic-Roles-of-CD4-and-CD8-T-Cells-in-7-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,15]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2008,5,15]]},"published-print":{"date-parts":[[2008,5,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-3059","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,15]]}}}